This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ATENOLOL CHLORTHALIDONE RESERPINE Medline Plus Health Information Blood Pressure Medicines High Blood Pressure

Hypertension, Vol 21, 335-343, Copyright © 1993 by American Heart Association

ARTICLES

Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group

Several imperatives drive the need to establish the merit of treating isolated systolic hypertension in the elderly. These include its higher prevalence with age, the associated excess cardiovascular risks, and the rapid aging of the population. The Systolic Hypertension in the Elderly Program demonstrated a significant reduction in stroke incidence (fatal and nonfatal) (36%, equivalent to preventing 30 strokes per 1,000 participants per 5 years). A 27% reduction in coronary heart disease incidence and a 32% reduction in all major cardiovascular events were also achieved (equivalent to the prevention of 16 and 55 events per 1,000 participants per 5 years, respectively). These results were associated with a treatment regimen in which the primary agent was low-dose chlorthalidone. The benefits accrued to all subgroups identified based on baseline age, race and sex, blood pressure, serum cholesterol levels, and electrocardiographic abnormalities. The reduction in coronary disease is consistent with predictions based on prospective epidemiological studies and is concordant with other recent intervention trials. It is a reasonable inference from the Systolic Hypertension in the Elderly Program findings that middle-aged as well as older people with isolated systolic hypertension, and people with less severe degrees of this condition, particularly when other risk factors are present, would benefit from such therapy. Another reasonable implication of the trial relates to the matter of preferred drug treatment regimens for diastolic hypertension, in middle-aged as well as older people.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. M. Brewster, G. A. van Montfrans, and J. Kleijnen Systematic Review: Antihypertensive Drug Therapy in Black Patients Ann Intern Med, October 19, 2004; 141(8): 614 - 627. [Abstract] [Full Text] [PDF]

				K. M. Field, J. L. Pepin, and M. D. Mehta Knowing When to Play the Ace: The Use and Under Use of Ace Inhibitors in Primary Practice Journal of Pharmacy Practice, June 1, 2004; 17(3): 197 - 210. [Abstract] [PDF]

				J. Froom and J. Trilling Reducing Antihypertensive Medication Use in Nursing Home Patients Arch Fam Med, April 1, 2000; 9(4): 378 - 383. [Abstract] [Full Text] [PDF]

				H. Smulyan and M. E. Safar The Diastolic Blood Pressure in Systolic Hypertension Ann Intern Med, February 1, 2000; 132(3): 233 - 237. [Abstract] [Full Text] [PDF]

				J.-G. Wang, J. A. Staessen, L. Gong, L. Liu, and for the Systolic Hypertension in China Collaborat Chinese Trial on Isolated Systolic Hypertension in the Elderly Arch Intern Med, January 24, 2000; 160(2): 211 - 220. [Abstract] [Full Text] [PDF]

				E. D. Frohlich Reappearance of the J-Shaped Curve Hypertension, December 1, 1999; 34(6): 1179 - 1180. [Full Text] [PDF]

				M. J. Johnson, M. Williams, and E. S. Marshall Adherent and Nonadherent Medication-Taking in Elderly Hypertensive Patients Clin Nurs Res, November 1, 1999; 8(4): 318 - 335. [Abstract] [PDF]

				J. A. Staessen, R. Fagard, L. Thijs, H. Celis, W. H. Birkenhager, C. J. Bulpitt, P. W. de Leeuw, A. E. Fletcher, M.-R. Babarskiene, F. Forette, et al. Subgroup and Per-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly Arch Intern Med, August 10, 1998; 158(15): 1681 - 1691. [Abstract] [Full Text]

				M. Moser Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension? JAMA, June 10, 1998; 279(22): 1813 - 1816. [Abstract] [Full Text] [PDF]

				J. D. Curb, S. L. Pressel, J. A. Cutler, P. J. Savage, W. B. Applegate, H. Black, G. Camel, B. R. Davis, P. H. Frost, N. Gonzalez, et al. Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients With Isolated Systolic Hypertension JAMA, December 18, 1996; 276(23): 1886 - 1892. [Abstract] [PDF]

				J. D. Curb, R. D. Abbott, C. J. MacLean, B. L. Rodriguez, C. M. Burchfiel, D. S. Sharp, G. W. Ross, and K. Yano Age-Related Changes in Stroke Risk in Men With Hypertension and Normal Blood Pressure Stroke, May 1, 1996; 27(5): 819 - 824. [Abstract] [Full Text]

				N. R. Cook, J. Cohen, P. R. Hebert, J. O. Taylor, and C. H. Hennekens Implications of Small Reductions in Diastolic Blood Pressure for Primary Prevention Arch Intern Med, April 10, 1995; 155(7): 701 - 709. [Abstract] [PDF]